The Danish National Chronic Myeloid Neoplasia Registry

Autor: Marie Bak, Eh, Ibfelt, Stauffer Larsen T, Rønnov-Jessen D, Pallisgaard N, Madelung A, Udby L, Hc, Hasselbalch, Ow, Bjerrum, Cl, Andersen

Publikováno v: Clinical Epidemiology, Vol Volume 8, Pp 567-572 (2016)
Europe PubMed Central

Marie Bak,1 Else Helene Ibfelt,2 Thomas Stauffer Larsen,3 Dorthe Rønnov-Jessen,4 Niels Pallisgaard,5 Ann Madelung,6 Lene Udby,1 Hans Carl Hasselbalch,1 Ole Weis Bjerrum,7 Christen Lykkegaard Andersen1,7 1Department of Hematology, Zealand University

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::85cfa99efbd157e3b5f54aa579aca274
https://www.dovepress.com/the-danish-national-chronic-myeloid-neoplasia-registry-peer-reviewed-article-CLEP

The multidisciplinary approach to eosinophilia.

Autor: Thomsen GN; Department of Hematology, Odense University Hospital, Odense, Denmark., Christoffersen MN; Department of Hematology, Odense University Hospital, Odense, Denmark., Lindegaard HM; Department of Rheumatology, Odense University Hospital, Denmark; Research Unit for Rheumatology, Odense University Hospital, Odense, Denmark; University of Southern Denmark, Odense, Denmark., Davidsen JR; Department of Respiratory Medicine, Odense University Hospital, Denmark; Odense Respiratory Research Unit (ODIN), Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Hartmeyer GN; Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark., Assing K; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark., Mortz CG; Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, Denmark; University of Southern Denmark, Odense, Denmark., Martin-Iguacel R; Department of Infectious Diseases , Odense University Hospital, Odense, Denmark., Møller MB; Department of Pathology, Odense University Hospital, Odense, Denmark., Kjeldsen AD; Department of ORL- Head and Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark; University of Southern Denmark, Odense, Denmark., Havelund T; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark., El Fassi D; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Broesby-Olsen S; Department of Dermatology and Allergy Centre, Odense Research Centre for Anaphylaxis (ORCA), Odense University Hospital, Denmark; University of Southern Denmark, Odense, Denmark., Maiborg M; Department of Cardiology, Odense University Hospital, Odense, Denmark., Johansson SL; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark., Andersen CL; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Centre for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Vestergaard H; Department of Hematology, Odense University Hospital, Odense, Denmark., Bjerrum OW; Department of Hematology, Odense University Hospital, Odense, Denmark.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 May 18; Vol. 13, pp. 1193730. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.

Autor: Huuhtanen J; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland.; Department of Computer Science, Aalto University, Espoo, Finland., Ilander M; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland., Yadav B; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland., Dufva OM; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland., Lähteenmäki H; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland., Kasanen T; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland., Klievink J; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland., Olsson-Strömberg U; Department of Medical Sciences, Uppsala University and Hematology Section, Uppsala University Hospital, Uppsala, Sweden., Stentoft J; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Richter J; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Koskenvesa P; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland., Höglund M; Department of Medical Sciences, Uppsala University and Hematology Section, Uppsala University Hospital, Uppsala, Sweden., Söderlund S; Department of Medical Sciences, Uppsala University and Hematology Section, Uppsala University Hospital, Uppsala, Sweden., Dreimane A; Department of Medical and Health Sciences, Linköping University, Department of Hematology, County Council of Östergötland, Linköping, Sweden., Porkka K; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Gedde-Dahl T; Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Gjertsen BT; Department of Internal Medicine, Hematology Section, Haukeland University Hospital and Department of Clinical Science, University of Bergen, Bergen, Norway., Stenke L; Department of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden., Myhr-Eriksson K; Department of Internal Medicine, Sunderby Hospital, Luleå, Sweden., Markevärn B; Department of Hematology, Umeå University Hospital, Umeå, Sweden., Lübking A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Dimitrijevic A; Department of Hematology, Odense University Hospital, Odense, Denmark., Udby L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Bjerrum OW; Department of Hematology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Hjorth-Hansen H; Department of Hematology, St. Olavs Hospital, Trondheim, Norway.; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Mustjoki S; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.; Hematology Research Unit Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2022 Sep 01; Vol. 132 (17).

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.

Autor: Knudsen TA; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Skov V; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Stevenson K; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Werner L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Duke W; Division of Hematology, Brigham and Women's Hospital, Boston, MA., Laurore C; Division of Hematology, Brigham and Women's Hospital, Boston, MA., Gibson CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Nag A; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA., Thorner AR; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA., Wollison B; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA., Hansen DL; Department of Hematology, Odense University Hospital, Odense, Denmark., Ellervik C; Department of Data and Innovation Support, Region Zealand, Soroe, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA.; Department of Pathology, Harvard Medical School, Boston, MA., El Fassi D; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Hematology, Herlev and Gentofte Hospital, Herlev, Denmark.; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., de Stricker K; Department of Pathology, Odense University Hospital, Odense, Denmark., Ocias LF; Statens Serum Institut, Copenhagen, Denmark., Brabrand M; Department of Hematology, Odense University Hospital, Odense, Denmark., Bjerrum OW; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., Overgaard UM; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., Frederiksen M; Department of Hematology, Hospital of Southern Jutland, Haderslev, Denmark., Kristensen TK; Department of Pathology, Odense University Hospital, Odense, Denmark., Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark., Mourits-Andersen T; Department of Hematology, Hospital of South West Jutland, Esbjerg, Denmark., Severinsen MT; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Stentoft J; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Starklint J; Department of Hematology, Holstebro Hospital, Holstebro, Denmark; and., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Kjaer L; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Larsen TS; Department of Hematology, Odense University Hospital, Odense, Denmark., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mullally A; Division of Hematology, Brigham and Women's Hospital, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute, Cambridge, MA.

Publikováno v: Blood advances [Blood Adv] 2022 Apr 12; Vol. 6 (7), pp. 2107-2119.

[Blodsygdomme - en smeltedigel med rige perspektiver].

Autor: Bjerrum OW; ole.weis.bjerrum@rsyd.dk., Hokland P; phokland@clin.au.dk.

Publikováno v: Ugeskrift for laeger [Ugeskr Laeger] 2021 Oct 18; Vol. 183 (42).